Johnson & Johnson says additional dose boosts Covid vaccine efficacy
The two-dose regimen prevented 75% of moderate to severe Covid cases in all countries where it was tested — and 94% of such cases in the U.S.
Related Articles
Can investing in infectious disease pay off? Vir Biotechnology’s tightrope walk shows it’s a struggle
In 2017, Vir Biotechnology’s founders threw millions at infectious disease. Covid made them look like geniuses. The road since then has been far rockier.
The Landline’s Not Dead (at Least at the Masters)
Augusta National Golf Club has long forbidden cellphones for almost anyone at its hallowed tournament, but patrons delight in making free calls the old-school way.
High Path Avian Influenza detected in North Carolina dairy herd
The National Veterinary Services Laboratory has detected Highly Pathogenic Avian Influenza in a dairy herd in North Carolina. HPAI has previously been detected in dairy…
Weekly U.S. Influenza Surveillance Report
Learn more about the weekly influenza surveillance report (FluView) prepared by the Influenza Division.
CDC to doctors: Look out for bird flu infections among dairy farm workers
The CDC urged medical practitioners on Friday to be on the lookout for people who might have contracted H5N1 bird flu from cows.
Neonatal Elizabethkingia anophelis meningitis originating from the water reservoir of an automated infant milk dispenser, the Netherlands, February 2024
Elizabethkingia anophelis is a multidrug-resistant pathogen causing high mortality and morbidity in adults with comorbidities and neonates. We report a Dutch case of E. anophelis…
Weekly U.S. Influenza Surveillance Report
Learn more about the weekly influenza surveillance report (FluView) prepared by the Influenza Division.
Covid’s scientific silver lining: A chance to watch the human immune system respond in real time
Covid wreaked havoc on the world. It also provided an unprecedented look at the human immune system.